Potential causes include that both trials utilized ASOs targeting sense repeat-derived mRNAs, whereas preclinical work has demonstrated that both sense- and antisense-repeat derived RNA species are present in C9orf72 FTD/ALS [41] and both are neurotoxic in animal studies [42]. The gene discussed is C9orf72; the disease is amyotrophic lateral sclerosis.